Clinicopathological correlates of depression in early Alzheimer’s disease in the NACC

International Journal of Geriatric Psychiatry

Volumn 31, Issue 12, 2016, Pages 1301-1311

  McCutcheon, Sarah T ^a   Han, Dingfen ^b   Troncoso, Juan ^b   Koliatsos, Vassilis E ^b   Albert, Marilyn ^b   Lyketsos, Constantine G ^b   Leoutsakos, Jeannie Marie S ^b  

^a UNIVERSITY OF IOWA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer s disease; dementia; late life depression; mild cognitive impairment; neuropathology; neuropsychiatric symptoms

Indexed keywords

BENZODIAZEPINE;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; EDUCATION; FEMALE; GERIATRIC DEPRESSION SCALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENTAL DISEASE; MILD COGNITIVE IMPAIRMENT; NEUROFIBRILLARY TANGLE; PREDICTION; SENILE PLAQUE; TRANSIENT ISCHEMIC ATTACK; VERY ELDERLY; AMYLOID PLAQUE; BRAIN; CASE CONTROL STUDY; COGNITIVE DEFECT; DEMENTIA; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; REGRESSION ANALYSIS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AUTOPSY; BRAIN; CASE-CONTROL STUDIES; COGNITIVE DYSFUNCTION; DEMENTIA; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PLAQUE, AMYLOID; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS;

EID: 84959152485     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.4435     Document Type: Article

References (50)

1. Alexopoulos EC. 2010. Introduction to multivariate regression analysis. Hippokratia 14(Suppl 1): 23–28.
2. Alexopoulos GS, Gunning-Dixon FM, Latoussakis V, Kanellopoulos D, Murphy CF. 2008. Anterior cingulate dysfunction in geriatric depression. Int J Geriatr Psychiatry 23: 347–355.
3. Armstrong RA, Lantos PL, Cairns NJ. 2005. Overlap between neurodegenerative disorders. Neuropathology 25: 111–124.
4. Banerjee S, Hellier J, Dewey M, et al. 2011. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet 378: 403–411.
5. Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K. 2006. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry 63: 273–279.
6. Barnes DE, Yaffe K, Byers AL, et al. 2012. Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry 69: 493–498.
7. Beekly DL, Ramos EM, Van Belle G, et al. 2004. The National Alzheimer’s Coordinating Center (NACC) Database: an Alzheimer disease database. Alzheimer Dis Assoc Disord 18: 270–277.
8. Braak H, Braak E. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239–259.
9. Butters MA, Klunk WE, Mathis CA, et al. 2008. Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B. Alzheimer Dis Assoc Disord 22: 261–268.
10. Cummings JL, Mega M, Gray K, et al. 1994. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44: 2308–2314.
11. Dhikav V, Sethi M, Anand KS. 2014. Medial temporal lobe atrophy in Alzheimer’s disease/mild cognitive impairment with depression. Br J Radiol 87: 20140150.
12. Di Iulio F, Palmer K, Blundo C, et al. 2010. Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer’s disease and mild cognitive impairment subtypes. Int Psychogeriatr 22: 629–640.
13. Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF 3rd. 2013. Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry 202: 329–335.
14. Dolan D, Troncoso J, Resnick SM, et al. 2010. Age, Alzheimer’s disease and dementia in the Baltimore Longitudinal Study of Ageing. Brain 133: 2225–2231.
15. Folstein MF, Folstein SE, Mchugh PR. 1975. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198.
16. Garre-Olmo J, Lopez-Pousa S, Vilalta-Franch J, et al. 2003. Evolution of depressive symptoms in Alzheimer disease: one-year follow-up. Alzheimer Dis Assoc Disord 17: 77–85.
17. Hirono N, Mori E, Ishii K, et al. 1998. Frontal lobe hypometabolism and depression in Alzheimer’s disease. Neurology 50: 380–383.
18. Hoogendijk WJ, Sommer IE, Pool CW, et al. 1999. Lack of association between depression and loss of neurons in the locus coeruleus in Alzheimer disease. Arch Gen Psychiatry 56: 45–51.
19. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. 1982. A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566–572.
20. Hyman BT, Phelps CH, Beach TG, et al. 2012. National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement 8: 1–13.
21. Khundakar AA, Thomas AJ. 2015. Neuropathology of depression in Alzheimer’s disease: current knowledge and the potential for new treatments. J Alzheimers Dis 44: 27–41.
22. Kitt CA, Walker LC, Molliver ME, Price DL. 1989. Serotoninergic neurites in senile plaques in cingulate cortex of aged nonhuman primate. Synapse 3: 12–18.
23. Koliatsos VE, Martin LJ, Walker LC, et al. 1988. Topographic, non-collateralized basal forebrain projections to amygdala, hippocampus, and anterior cingulate cortex in the rhesus monkey. Brain Res 463: 133–139.
24. Lee GJ, Lu PH, Hua X, et al. 2012. Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer’s disease-related regions. Biol Psychiatry 71: 814–821.
25. Leon-Salas B, Olazaran J, Cruz-Orduna I, et al. 2013. Quality of life (QoL) in community-dwelling and institutionalized Alzheimer’s disease (AD) patients. Arch Gerontol Geriatr 57: 257–262.
26. Liu Y, Yoo MJ, Savonenko A, et al. 2008. Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer’s disease. J Neurosci 28: 13805–13814.
27. Lopez OL, Becker JT, Sweet RA, Martin-Sanchez FJ, Hamilton RL. 2006. Lewy bodies in the amygdala increase risk for major depression in subjects with Alzheimer disease. Neurology 67: 660–665.
28. Lyketsos CG, Olin J. 2002. Depression in Alzheimer’s disease: overview and treatment. Biol Psychiatry 52: 243–252.
29. Lyness SA, Zarow C, Chui HC. 2003. Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis. Neurobiol Aging 24: 1–23.
30. McKhann G, Drachman D, Folstein M, et al. 1984. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34: 939–944.
31. Mirra SS, Heyman A, Mckeel D, et al. 1991. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41: 479–486.
32. Modrego PJ, Ferrandez J. 2004. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol 61: 1290–1293.
33. Morris JC, Weintraub S, Chui HC, et al. 2006. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord 20: 210–216.
34. O’Bryant SE, Waring SC, Cullum CM, et al. 2008. Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer’s research consortium study. Arch Neurol 65: 1091–1095.
35. O’Brien J, Thomas A, Ballard C, et al. 2001. Cognitive impairment in depression is not associated with neuropathologic evidence of increased vascular or Alzheimer-type pathology. Biol Psychiatry 49: 130–136.
36. Petersen RC. 2004. Mild cognitive impairment as a diagnostic entity. J Intern Med 256: 183–194.
37. Qiu WQ, Zhu H, Dean M, et al. 2015. Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer’s disease. Int J Geriatr Psychiatry. [Epub ahead of print].
38. Rapp MA, Schnaider-Beeri M, Purohit DP, et al. 2008. Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression. Am J Geriatr Psychiatry 16: 168–174.
39. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. 1980. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 7: 486–488.
40. Rosenberg PB, Drye LT, Martin BK, et al. 2010. Sertraline for the treatment of depression in Alzheimer disease. Am J Geriatr Psychiatry 18: 136–145.
41. Rosenberg PB, Mielke MM, Appleby BS, et al. 2013. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry 21: 685–695.
42. Rosenberg PB, Mielke MM, Han D, et al. 2012. The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer’s disease. Int J Geriatr Psychiatry 27: 1248–1257.
43. Sheikh JI, Yesavage JA. 1986. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clinical Gerontology: A Guide to Assessment and Intervention 165-173. The Haworth Press: NY.
44. Steele C, Rovner B, Chase GA, Folstein M. 1990. Psychiatric symptoms and nursing home placement of patients with Alzheimer’s disease. Am J Psychiatry 147: 1049–1051.
45. Steenland K, Karnes C, Seals R, et al. 2012. Late-life depression as a risk factor for mild cognitive impairment or Alzheimer’s disease in 30 US Alzheimer’s disease centers. J Alzheimers Dis 31: 265–275.
46. Sweet RA, Hamilton RL, Butters MA, et al. 2004. Neuropathologic correlates of late-onset major depression. Neuropsychopharmacology 29: 2242–2250.
47. Taylor WD, Aizenstein HJ, Alexopoulos GS. 2013. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry 18: 963–974.
48. Tighe SK, Oishi K, Mori S, et al. 2012. Diffusion tensor imaging of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer’s dementia. J Neuropsychiatry Clin Neurosci 24: 484–488.
49. Wilson RS, Schneider JA, Bienias JL, et al. 2003. Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology 61: 1102–1107.
50. Zahodne LB, Gongvatana A, Cohen RA, et al. 2013. Are apathy and depression independently associated with longitudinal trajectories of cortical atrophy in mild cognitive impairment? Am J Geriatr Psychiatry 21: 1098–1106.